Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease M Uhde, M Ajamian, G Caio, R De Giorgio, A Indart, PH Green, EC Verna, ... Gut 65 (12), 1930-1937, 2016 | 288 | 2016 |
Markers of celiac disease and gluten sensitivity in children with autism NM Lau, PHR Green, AK Taylor, D Hellberg, M Ajamian, CZ Tan, ... PloS one 8 (6), e66155, 2013 | 183 | 2013 |
Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems M Ajamian, D Steer, G Rosella, PR Gibson PloS one 14 (1), e0210728, 2019 | 160 | 2019 |
Gluten-free and low-FODMAP sourdoughs for patients with coeliac disease and irritable bowel syndrome: A clinical perspective JG Muir, JE Varney, M Ajamian, PR Gibson International journal of food microbiology 290, 237-246, 2019 | 64 | 2019 |
Expression of C-reactive protein and serum amyloid A in early to late manifestations of Lyme disease M Uhde, M Ajamian, X Li, GP Wormser, A Marques, A Alaedini Clinical infectious diseases 63 (11), 1399-1404, 2016 | 31 | 2016 |
Epitope-specific evolution of human B cell responses to Borrelia burgdorferi VlsE protein from early to late stages of Lyme disease E Jacek, KS Tang, L Komorowski, M Ajamian, C Probst, B Stevenson, ... The Journal of Immunology 196 (3), 1036-1043, 2016 | 30 | 2016 |
Effect of gluten ingestion and FODMAP restriction on intestinal epithelial integrity in patients with irritable bowel syndrome and self‐reported non‐coeliac gluten sensitivity M Ajamian, G Rosella, ED Newnham, JR Biesiekierski, JG Muir, ... Molecular nutrition & food research 65 (5), 1901275, 2021 | 28 | 2021 |
Serologic markers of Lyme disease in children with autism M Ajamian, BE Kosofsky, GP Wormser, AM Rajadhyaksha, A Alaedini JAMA 309 (17), 1771-1773, 2013 | 16 | 2013 |
Anti-neural antibody response in patients with post-treatment Lyme disease symptoms versus those with myalgic encephalomyelitis/chronic fatigue syndrome M Ajamian, M Cooperstock, GP Wormser, SD Vernon, A Alaedini Brain, behavior, and immunity 48, 354, 2015 | 5 | 2015 |
Associations between subclass profile of IgG response to gluten and the gastrointestinal and motor symptoms in children with cerebral palsy R Stenberg, M Uhde, M Ajamian, PH Green, A Myleus, A Alaedini Journal of pediatric gastroenterology and nutrition 73 (3), 367-375, 2021 | 3 | 2021 |
Green, & P. H., Alaedini, A.(2016). Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease M Uhde, M Ajamian, G Caio, R De Giorgio, A Indart Gut 65 (12), 1930-1937, 0 | 3 | |
Intestinal barrier biomarkers in clinical evaluation of patients with inflammatory bowel disease T Mogilevski, AL Nguyen, M Ajamian, R Smith, S Rosella, MP Sparrow, ... European Journal of Gastroenterology & Hepatology 36 (3), 271-280, 2024 | 2 | 2024 |
Autism and Lyme disease—Reply M Ajamian, AM Rajadhyaksha, A Alaedini JAMA 310 (8), 857-857, 2013 | 1 | 2013 |
Su393 THE ROLE OF ILLNESS PERCEPTIONS IN TREATMENT RESPONSE OF ADULTS WITH IBS UNDERGOING LOW FODMAP DIET INTERVENTION: A PROSPECTIVE STUDY. L Manning, L Van Oudenhove, J Biesiekierski Gastroenterology 160 (6), S-678-S-679, 2021 | | 2021 |
Investigating Markers of Intestinal Barrier Dysfunction in Gastrointestinal Diseases MA Ajamian Monash University, 2019 | | 2019 |
The utility of serum zonulin as a marker of gastrointestinal dysfunction M Ajamian, G Rosella, JG Muir, PR Gibson JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32, 155-155, 2017 | | 2017 |
Reply to Naktin M Uhde, M Ajamian, GP Wormser, AR Marques, A Alaedini Clinical Infectious Diseases 64 (8), 1145-1146, 2017 | | 2017 |
Luminal Clinical M AJAMIAN, G ROSELLA, JG MUIR, PR GIBSON Journal of Gastroenterology and Hepatology 32 (2), 155Н171, 2017 | | 2017 |